Columbia Laboratories, Inc.

Providing specialty pharmaceuticals that treat infertility and other women’s healthcare conditions in a targeted, patient-friendly way.

Home

About Us

Our Vision & Goals

Management Team

Board of Directors

Strategic Alliances

Our Products

Research and Development

Drug Delivery Technology

Investor Relations

Contact Us

Contact Form

Driving Directions & Map

Careers

Job Listing

Research & Development 
Columbia’s research and development programs are the heart of our business and the engines that drive our growth.  We are advancing a diversified portfolio of products to treat women’s healthcare and endocrinologic conditions, including two currently-marketed products for which potential new indications are being evaluated.  To learn more about an individual product, select an item from the chart below.
Preclinical Phase I Phase II Phase III
PROCHIEVE® 8% to reduce the risk of preterm birth in women with a short cervix
PROCHIEVE® 4% for endometrial hyperplasia in HRT patients
Vaginal lidocaine for dysmenorrhea
Vaginal testosterone for uterine fibroids
Desmopressin buccal tablet for nocturnal enuresis
Vaginal carbamide peroxide
Various projects using BDS for vaginal drug delivery

 

Legal  |  Glossary |  Site Map

Copyright 2007 Columbia Laboratories, Inc., All Rights Reserved.